- Home
- EQ vs SOWG Comparison
EQ vs SOWG Comparison
Compare EQ & SOWG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EQ
- SOWG
- Stock Information
- Founded
- EQ 2017
- SOWG 2010
- Country
- EQ United States
- SOWG United States
- Employees
- EQ N/A
- SOWG N/A
- Industry
- EQ Biotechnology: Pharmaceutical Preparations
- SOWG Packaged Foods
- Sector
- EQ Health Care
- SOWG Consumer Staples
- Exchange
- EQ Nasdaq
- SOWG Nasdaq
- Market Cap
- EQ 24.8M
- SOWG 23.1M
- IPO Year
- EQ 2018
- SOWG N/A
- Fundamental
- Price
- EQ $0.63
- SOWG $2.61
- Analyst Decision
- EQ Buy
- SOWG Strong Buy
- Analyst Count
- EQ 2
- SOWG 2
- Target Price
- EQ $5.00
- SOWG $23.00
- AVG Volume (30 Days)
- EQ 130.9K
- SOWG 211.5K
- Earning Date
- EQ 11-13-2024
- SOWG 02-20-2025
- Dividend Yield
- EQ N/A
- SOWG N/A
- EPS Growth
- EQ N/A
- SOWG N/A
- EPS
- EQ N/A
- SOWG 0.21
- Revenue
- EQ $45,914,000.00
- SOWG $40,130,971.00
- Revenue This Year
- EQ $4.76
- SOWG $122.17
- Revenue Next Year
- EQ N/A
- SOWG N/A
- P/E Ratio
- EQ N/A
- SOWG $12.16
- Revenue Growth
- EQ 7.70
- SOWG 508.45
- 52 Week Low
- EQ $0.49
- SOWG $1.98
- 52 Week High
- EQ $3.25
- SOWG $24.83
- Technical
- Relative Strength Index (RSI)
- EQ 37.33
- SOWG 41.77
- Support Level
- EQ $0.49
- SOWG $2.70
- Resistance Level
- EQ $0.73
- SOWG $3.00
- Average True Range (ATR)
- EQ 0.08
- SOWG 0.40
- MACD
- EQ -0.01
- SOWG 0.11
- Stochastic Oscillator
- EQ 38.92
- SOWG 28.10
About EQ Equillium Inc.
Equillium Inc is a biotechnology developing therapies to treat severe autoimmune and inflammatory disorders. Its pipeline includes itolizumab, a first-in-class antibody targeting the CD6-ALCAM pathway which plays a key role in the modulation of effector T cells - currently in a Ph 3 study for patients with acute graft-versus-host disease and a Ph 1b study for patients with lupus nephritis. EQ101, a first-in-class cytokine inhibitor that selectively targets IL-2, IL-9, and IL-15 is Ph2-ready and expected to begin enrolling patients in an alopecia areata study in 2H 2022. EQ102, a cytokine inhibitor that selectively targets IL-15 and IL-21, is ready for clinical development and expected to begin enrolling patients in a Ph 1study including patients with celiac disease.
About SOWG Sow Good Inc. Common Stock
Sow Good Inc is engaged in manufacturing and marketing freeze-dried fruits, vegetables, snacks, smoothies, and soups. The company also sells gluten-free granola products under the Sow Good brand. The company is developing a freeze-dried candy market and snack manufacturing to provide consumers with flavorful freeze-dried treats.